CVR: 44308266
Secondary names: Combotope ApS, Sweetspot Therapeutics ApS
DKK -633,359
Gross profit
Net result: DKK -934,394
MOLIOR HOLDING ApS, Kolab Holding ApS
CVR · view ownership and management
Owner registered: MOLIOR HOLDING ApS
CVR · 18/11/2024
View the full event history
Combotope Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Nyboe Jakobsen and Klas Ola Blixt. The company is owned by MOLIOR HOLDING ApS and Kolab Holding ApS. In 2025, the company reported a gross profit of DKK -633,359 and a net result of DKK -934,394. Equity in the 2025 report amounted to DKK 1,070,294.
Selskabets formål er drive erhvervsmæssig virksomhed inden for service, handel og/eller produktion, samt enhver aktivitet, der står i forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringCombotope Therapeutics ApS was founded on 14 September 2023.
Combotope Therapeutics ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Combotope Therapeutics ApS is owned by MOLIOR HOLDING ApS and Kolab Holding ApS.
In 2025, Combotope Therapeutics ApS reported a gross profit of DKK -633,359.
The management of Combotope Therapeutics ApS consists of Søren Nyboe Jakobsen and Klas Ola Blixt.
Combotope Therapeutics ApS is located at Ole Maaløes Vej 3, 2200 København N.
Claim this page to add your logo and social links. Free to get started.
Combotope Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -633,359, and the net result was DKK -934,394.
Address changed to Ole Maaløes Vej 3 3, 2200 København N (March 17, 2026).
Contact info changed: new email: [email protected] (March 17, 2026).
Combotope Therapeutics ApS has published its interim report for the period September 14, 2023 – December 31, 2024.
As of November 18, 2024, MOLIOR HOLDING ApS is registered as an owner of Combotope Therapeutics ApS with an ownership share of 33%.
As of June 25, 2024, Kolab Holding ApS is registered as an owner of Combotope Therapeutics ApS with an ownership share of 50%.
As of September 14, 2023, Søren Nyboe Jakobsen is registered as director of Combotope Therapeutics ApS.
As of September 14, 2023, Klas Ola Blixt is registered as director of Combotope Therapeutics ApS.
Combotope Therapeutics ApS was founded on September 14, 2023.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
